From: Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours
Type of tumour(n) | Sensitivity(%) | Specificity (%) |
---|---|---|
(95%CI(%)) | (95%CI(%)) | |
Endometrial cancer (41) | 87.8 (73.8-95.9) | 75.9 (62.8-86.1) |
Low grade(14) | 85.7 (57.2-98.2) | - |
High Grade(27) | 88.9 (70.8-97.7) | - |
Stage I (29) | 86.2 (68.3-96.1) | - |
Stage II and above(12) | 91.7 (61.5-99.8) | - |
Ovarian cancer(26) | 61.5 (40.6-79.8) | 75.9 (62.8-86.1) |
Low Grade(7) | 71.4 (29.0-96.3) | - |
High Grade(19) | 57.9 (33.5-79.8) | - |
Stage I(8) | 75.0 (34.9-96.8) | - |
Stage II and above(15) | 53.3 (26.6-78.7) | - |